Table 4. Persistence patterns of different class of anti-migraine drugs.
Continuers | Switchers | Discontinuers | P-value | |
---|---|---|---|---|
N (%) | N (%) | N (%) | ||
NSAIDs | 36 (8.6) | 62 (14.9) | 317 (76.3) | 0.001 |
Combination analgesics | 41 (10.7) | 70 (18.4) | 269 (70.7) | <0.001 |
Triptans | 156 (57.5) | 38 (14.0) | 77 (28.4) | 0.025 |
Triptans + NSAIDs | 187 (54.5) | 50 (14.5) | 106 (30.9) | 0.038 |
Prophylaxis drugs | 32 (17.0) | 16 (8.5) | 140 (74.4) | 0.002 |
Total | 452 (28.5) | 236 (14.8) | 909 (57.3) | <0.001 |
* Total (1597 N) Patients